Creation versus destruction of T cell epitopes in the class II MHC pathway.
about
MHC Class II Auto-Antigen Presentation is UnconventionalThe protein structure determines the sensitizing capacity of Brazil nut 2S albumin (Ber e1) in a rat food allergy model.Healthy individuals have Goodpasture autoantigen-reactive T cells.An antigenic peptide produced by reverse splicing and double asparagine deamidationDivergent paths for the selection of immunodominant epitopes from distinct antigenic sources.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensEnhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.Cathepsin G: roles in antigen presentation and beyond.Generation of MHC class I ligands in the secretory and vesicular pathways.Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.Determinants of immunodominance for CD4 T cells.Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitroThe human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage siteEvaluation of the host transcriptional response to human cytomegalovirus infection.Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.
P2860
Q26800138-DE7EB1D4-6B32-4FF9-BBEC-17B8A4DF4A5CQ30355137-F7594F2C-7A81-4743-8251-61666702A21AQ33316272-35B1A059-B0F7-4299-90CB-E6E67308FA2AQ34192290-4FB245F0-70B2-4288-93A3-BE0FDB52F425Q34561569-106896AD-6AAD-490A-BE7B-3DD637D1FC97Q35622999-6B23DAD1-374E-4B42-87DE-2D00E06856C2Q36017488-6F3F5F97-725E-422A-B31C-E657E93A67E1Q36228836-A46B5964-E550-45B9-A5F5-615B45B7F283Q37632012-9CBB203D-C07E-46F9-97B5-6175C1EF4038Q37851046-0E77E459-DF24-443F-8AE1-FA1188D3A72CQ38060734-CBFBE784-6898-4F0D-9736-24E2B34D5C21Q38313559-DD43B73A-541F-45E9-BEEC-31086F37E013Q39597125-7B5C6452-6E7F-4DFA-9199-DE212C217782Q42728565-31A1B0A9-0034-4906-B2E6-84F7D9FA8B0FQ51597552-7A4F116B-D63C-4C21-8947-8AA854F8BA24Q53017764-6478164D-B536-40EE-865F-878C7F56712CQ54317876-E7B40E74-5B52-4F96-B8C5-33AAF39E1CE1
P2860
Creation versus destruction of T cell epitopes in the class II MHC pathway.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@ast
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@en
type
label
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@ast
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@en
prefLabel
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@ast
Creation versus destruction of T cell epitopes in the class II MHC pathway.
@en
P2093
P1476
Creation versus destruction of T cell epitopes in the class II MHC pathway
@en
P2093
P2860
P356
10.1111/J.1749-6632.2003.TB06028.X
P407
P577
2003-04-01T00:00:00Z